Afatinib Dimaleate Entèmedyè CAS 314771-76-1 Pite> 99.0% (HPLC) Faktori
Ruifu Chimik Pwovizyon pou Entèmedyè nan Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino) acetaldehyde Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Asid Hydrochloride CAS 848133-35-7
Diethylphosphonoacetic Asid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-yon sèl CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineCAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl)oxy)quinazolin-4-AmineCAS 314771-88-5
Non Chimik | (S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine |
Sinonim | N4-(3-Chloro-4-Fluorophenyl)-7-[[(3S)-Tetrahydro-3-Furanyl]oxy] -4,6-Quinazolinediamine;Afatinib enpurte B;Afatinib-des (4-Dimethylamino-2-en-1-oxo)butil;Des(4-Dimethylamino-2-en-1-oxo)butil Afatinib |
Nimewo CAS | 314771-76-1 |
Nimewo CAT | RF-PI2028 |
Estati Stock | Nan stock, pwodiksyon kapasite 100MT/ane |
Fòmil molekilè | C18H16ClFN4O2 |
Pwa molekilè | 374.8 |
Pwen bouyi | 559.0±50.0℃ |
Dansite | 1.473±0.060 g/cm3 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Limyè jòn poud jòn |
Idantifikasyon | Tan Retansyon Prensipal Pik nan HPLC ta dwe koresponn ak estanda a |
Pite / Metòd analiz | >99.0% (HPLC) |
Pèt sou siye | <0.50% |
Rezid sou ignisyon | <0.20% |
Single enpurte | <0.50% |
Enpurte total | <1.00% |
Metal lou (tankou Pb) | ≤20ppm |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Afatinib Dimaleate (CAS: 850140-73-7) |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine (CAS: 314771-76-1) se yon entèmedyè nan Afatinib Dimaleate. (CAS: 850140-73-7).Afatinib se dezyèm jenerasyon ki pisan ak irevokabl doub inibitè nan reseptè faktè kwasans epidèm (EGFR) ak reseptè faktè kwasans epidèm imen 2 (HER2) tirozin kinaz, devlope pa Boehringer Ingelheim, Almay.Li kapab irevokabl anpeche aktivite tirozin kinaz la lè li sibi reyaksyon Michael ak gwoup thiol cysteine nan pozisyon 797 EGFR la.Fonksyon: 1. Tankou Lapatinib ak Neratinib, Afatinib se yon inhibitor pwoteyin kinaz ki tou irevokabl inibit reseptè faktè kwasans epidèm imen 2 (Her2) ak reseptè faktè kwasans epidèm (EGFR) kinaz.2. Afatinib pa sèlman aktif kont mitasyon EGFR ki vize pa TKI premye jenerasyon tankou erlotinib oswa gefitinib, men tou kont mitasyon tankou T790M ki pa sansib a terapi estanda sa yo.Akòz aktivite adisyonèl li kont Her2, yo ap envestige l pou kansè nan tete ak lòt kansè ki lakòz EGFR ak Her2.3. Afatinib se yon dwòg pou tretman premye liy pasyan ki gen diferan kalite metastatik (EGFR mitasyon pozitif) ki pa ti selil kansè nan poumon (NSCLC).Li aji kòm yon inibitè kovalan irevokabl nan reseptè tirozin kinas reseptè faktè kwasans epidèm (EGFR) ak erbB-2 (HER2).